[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CR20210104A - Derivados de heteroarilo bicíclicos - Google Patents

Derivados de heteroarilo bicíclicos

Info

Publication number
CR20210104A
CR20210104A CR20210104A CR20210104A CR20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A CR 20210104 A CR20210104 A CR 20210104A
Authority
CR
Costa Rica
Prior art keywords
bicyclic heteroaryl
compounds
heteroaryl derivatives
sup
derivatives
Prior art date
Application number
CR20210104A
Other languages
English (en)
Inventor
Jennifer Louise Carter
Hasane Ratni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20210104A publication Critical patent/CR20210104A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

<p>La invención proporciona nuevos compuestos heteroarilo bicíclicos que presentan la Fórmula general (I)</p> <p><img src="data:image/png;base64,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 (***)
CR20210104A 2018-09-03 2019-09-02 Derivados de heteroarilo bicíclicos CR20210104A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18192219 2018-09-03
PCT/EP2019/073303 WO2020048904A1 (en) 2018-09-03 2019-09-02 Bicyclic heteroaryl derivatives

Publications (1)

Publication Number Publication Date
CR20210104A true CR20210104A (es) 2021-04-19

Family

ID=63490310

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20210104A CR20210104A (es) 2018-09-03 2019-09-02 Derivados de heteroarilo bicíclicos

Country Status (31)

Country Link
US (1) US12084461B2 (es)
EP (1) EP3846903B1 (es)
JP (1) JP7398435B2 (es)
KR (1) KR20210054515A (es)
CN (1) CN112566696B (es)
AR (1) AR116051A1 (es)
AU (1) AU2019336492B2 (es)
BR (1) BR112021002170A2 (es)
CA (1) CA3107593A1 (es)
CL (1) CL2021000486A1 (es)
CO (1) CO2021002415A2 (es)
CR (1) CR20210104A (es)
DK (1) DK3846903T3 (es)
ES (1) ES2966947T3 (es)
FI (1) FI3846903T3 (es)
HR (1) HRP20231663T1 (es)
HU (1) HUE064554T2 (es)
IL (1) IL281175B2 (es)
LT (1) LT3846903T (es)
MA (1) MA53541B1 (es)
MX (1) MX2021002087A (es)
PE (1) PE20210860A1 (es)
PH (1) PH12021550320A1 (es)
PL (1) PL3846903T3 (es)
PT (1) PT3846903T (es)
RS (1) RS64950B1 (es)
SG (1) SG11202102137SA (es)
SI (1) SI3846903T1 (es)
TW (1) TWI841592B (es)
UA (1) UA128482C2 (es)
WO (1) WO2020048904A1 (es)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994349A (en) 1997-10-27 1999-11-30 Howard University 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
EP1087934B1 (en) 1998-04-01 2004-02-25 Nortran Pharmaceuticals Inc. Aminocyclohexyl ether compounds and uses thereof
AU2528900A (en) 1999-02-12 2000-08-29 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US6448246B1 (en) 1999-05-25 2002-09-10 Neurogen Corporation Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands
AU775102B2 (en) 1999-09-13 2004-07-15 David M. Swope Composition and method for decreasing neurologic symptomatology
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US8703753B2 (en) 2005-09-15 2014-04-22 Biomas Ltd. Use of tellurium compounds for the treatment of actinic keratosis
JP5264890B2 (ja) 2007-05-11 2013-08-14 エフ.ホフマン−ラ ロシュ アーゲー アミロイドベータの調節剤としてのヘタリールアニリン
MX2010004309A (es) 2007-10-19 2010-05-03 Janssen Pharmaceutica Nv Moduladores de piperidinil y piperazinil de gamma-secretasa.
MX2011005046A (es) 2008-11-13 2011-06-01 Schering Corp Moduladores de gamma secretasa.
US8754100B2 (en) * 2009-02-26 2014-06-17 Eisai R&D Management Co., Ltd. Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
WO2010138901A1 (en) 2009-05-29 2010-12-02 Biogen Idec Ma Inc Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
CA2767764A1 (en) * 2009-07-13 2011-01-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8891284B2 (en) 2009-07-13 2014-11-18 Hewlett-Packard Development Company, L.P. Memristors based on mixed-metal-valence compounds
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
US8486967B2 (en) * 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines
US8703763B2 (en) * 2011-03-02 2014-04-22 Hoffmann-La Roche Inc. Bridged piperidine derivatives
EP2731948B1 (en) 2011-07-15 2015-09-09 Janssen Pharmaceuticals, Inc. Novel substituted indole derivatives as gamma secretase modulators
WO2014060112A1 (en) 2012-10-19 2014-04-24 Origenis Gmbh Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
JP6831372B2 (ja) * 2015-09-09 2021-02-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 架橋ピペリジン誘導体
CN108137579B (zh) 2015-12-10 2022-01-07 豪夫迈·罗氏有限公司 桥连哌啶衍生物
EP3475279B1 (en) 2016-06-27 2021-07-14 F. Hoffmann-La Roche AG Triazolopyridines as gamma-secretase modulators
AR109829A1 (es) * 2016-09-29 2019-01-30 Hoffmann La Roche Derivados de piperidina puenteados
EP3535266B1 (en) * 2016-11-01 2021-12-29 F. Hoffmann-La Roche AG Bicyclic heteroaryl derivatives
WO2018087018A1 (en) 2016-11-08 2018-05-17 F. Hoffmann-La Roche Ag Phenoxytriazoles
JP6904612B2 (ja) 2016-12-16 2021-07-21 パイプライン セラピューティクス, インコーポレイテッド 蝸牛シナプス障害を処置する方法
US11370802B2 (en) * 2018-01-22 2022-06-28 Hoffmann-La Roche, Inc. Triazolo-azepine derivatives

Also Published As

Publication number Publication date
SG11202102137SA (en) 2021-04-29
MA53541B1 (fr) 2024-02-29
TW202023649A (zh) 2020-07-01
RS64950B1 (sr) 2024-01-31
EP3846903B1 (en) 2023-10-25
UA128482C2 (uk) 2024-07-24
CN112566696A (zh) 2021-03-26
CA3107593A1 (en) 2020-03-12
AR116051A1 (es) 2021-03-25
PE20210860A1 (es) 2021-05-18
CN112566696B (zh) 2024-01-16
SI3846903T1 (sl) 2024-02-29
HUE064554T2 (hu) 2024-03-28
BR112021002170A2 (pt) 2021-05-04
CL2021000486A1 (es) 2021-07-30
MA53541A (fr) 2021-12-08
US20210323980A1 (en) 2021-10-21
WO2020048904A1 (en) 2020-03-12
JP7398435B2 (ja) 2023-12-14
PT3846903T (pt) 2023-12-14
DK3846903T3 (da) 2024-01-02
CO2021002415A2 (es) 2021-03-08
EP3846903A1 (en) 2021-07-14
FI3846903T3 (fi) 2023-12-19
IL281175B2 (en) 2024-01-01
IL281175B1 (en) 2023-09-01
AU2019336492B2 (en) 2024-10-31
KR20210054515A (ko) 2021-05-13
JP2021535178A (ja) 2021-12-16
TWI841592B (zh) 2024-05-11
AU2019336492A1 (en) 2021-01-07
PL3846903T3 (pl) 2024-05-06
IL281175A (en) 2021-04-29
PH12021550320A1 (en) 2021-10-04
US12084461B2 (en) 2024-09-10
HRP20231663T1 (hr) 2024-03-15
ES2966947T3 (es) 2024-04-25
LT3846903T (lt) 2024-01-10
MX2021002087A (es) 2021-04-28

Similar Documents

Publication Publication Date Title
CR20210247A (es) Nuevos compuestos heterocíclicos
PH12021500014A1 (en) Fused ring compounds
WO2020097537A3 (en) Fused ring compounds
MX2021002978A (es) Lactamas biciclicas y metodos de uso de las mismas.
WO2020243415A3 (en) Tead inhibitors and uses thereof
MX2021001433A (es) Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa.
CR20240238A (es) Compuestos de carbamoyl piridona tricíclicos con puente y su uso farmacéutico (divisional 2021-0486)
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
WO2017050791A8 (en) New bicyclic compounds as dual atx/ca inhibitors
MY196413A (en) Substituted Carbonucleoside Derivatives Useful as Anticancer Agents
MX2020009234A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos.
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
CR20220116A (es) Compuestos heterocíclicos
ZA202309446B (en) Rapamycin analogs and uses thereof
CR20220004A (es) Nuevos compuestos heterocíclicos
CR20220117A (es) Compuestos heterocíclicos
MX2023002224A (es) Compuestos heterociclicos.
MX2020002449A (es) Nuevos compuestos heterociclicos fungicidas.
MX2020006370A (es) Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas.
MX2023008634A (es) Análogos de rapamicina y usos de estos.
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
WO2018166993A3 (en) PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
MX2024010625A (es) Compuestos antibioticos, metodos de fabricacion de los mismos, composiciones farmaceuticas conteniendo los mismos y usos de los mismos.
WO2020139971A3 (en) Methods for making dimeric naphthalimides and solid state forms of the same
MX2021002087A (es) Derivados de heteroarilo biciclicos.